1. Home
  2. ELA vs IMRX Comparison

ELA vs IMRX Comparison

Compare ELA & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envela Corporation

ELA

Envela Corporation

HOLD

Current Price

$12.55

Market Cap

332.6M

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$4.66

Market Cap

366.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELA
IMRX
Founded
1965
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.6M
366.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ELA
IMRX
Price
$12.55
$4.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$11.50
$17.20
AVG Volume (30 Days)
98.0K
2.6M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
58.79
N/A
EPS
0.39
N/A
Revenue
$208,843,961.00
N/A
Revenue This Year
$19.13
N/A
Revenue Next Year
$2.46
N/A
P/E Ratio
$34.12
N/A
Revenue Growth
23.18
N/A
52 Week Low
$5.10
$1.10
52 Week High
$15.09
$10.08

Technical Indicators

Market Signals
Indicator
ELA
IMRX
Relative Strength Index (RSI) 52.23 37.32
Support Level $11.00 $6.26
Resistance Level $13.64 $8.48
Average True Range (ATR) 1.09 0.63
MACD -0.08 -0.11
Stochastic Oscillator 43.40 11.81

Price Performance

Historical Comparison
ELA
IMRX

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: